Table 176 Percent of patients with adverse drug events: anticoagulant-related IV heparin, United States, 2005a |
Population group |
Percent |
SE |
Total |
|
13.0 |
0.7 |
Age |
Under 65 |
14.0 |
1.9 |
65-74 |
11.7 |
1.1 |
75-84 |
13.5 |
1.2 |
85 and over |
14.3 |
2.2 |
Gender |
Female |
14.5 |
1.1 |
Male |
11.6 |
0.9 |
Race |
White |
13.0 |
0.8 |
Black |
10.7 |
2.0 |
Other |
17.5 |
3.7 |
Diabetes |
Yes |
13.6 |
1.2 |
No |
12.6 |
0.9 |
Obesity |
Yes |
12.2 |
1.8 |
No |
13.1 |
0.8 |
Cerebrovascular disease |
Yes |
14.6 |
1.4 |
No |
12.4 |
0.8 |
CHF/pulmonary edema |
Yes |
17.0 |
1.3 |
No |
10.5 |
0.8 |
COPD |
Yes |
13.9 |
1.3 |
No |
12.6 |
0.8 |
Smoking |
Yes |
15.1 |
1.8 |
No |
12.6 |
0.8 |
Corticosteroids |
Yes |
12.7 |
0.7 |
No |
16.8 |
3.1 |
Coronary artery disease |
Yes |
14.4 |
0.9 |
No |
9.5 |
1.1 |
Renal disease |
Yes |
16.2 |
1.3 |
No |
11.1 |
0.8 |
a Data include Medicare beneficiaries discharged from January to December.
Key: CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; SE: standard error.
Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System.